PubRank

J D Earle

Author PubWeight™ 75.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 2001 5.16
2 The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001 2.41
3 Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 1991 2.37
4 Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. Ophthalmology 2001 2.09
5 Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 1995 1.51
6 Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06. Int J Radiat Oncol Biol Phys 1998 1.49
7 Radiation therapy for glottic cancer using 6-MV photons. Cancer 1996 1.48
8 Impact of radiation dose and tumor size on large cell lymphoma patients in complete response after integrated CHOP-Bleo-radiation treatment protocol. Int J Radiat Oncol Biol Phys 1995 1.40
9 Long-term follow-up of radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004 1.40
10 Radiation therapy for squamous cell carcinoma of the tonsil. Mayo Clin Proc 1994 1.39
11 Linear accelerator sypervoltage radiation therapy: testicular tumors. Radiology 1968 1.38
12 The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch Ophthalmol 2001 1.34
13 Differential diagnosis between radiation and tumor plexopathy of the pelvis. Neurology 1985 1.28
14 Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer. J Clin Oncol 1993 1.25
15 Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989 1.16
16 Effects of irradiation on cortical bone and their time-related changes. A biomechanical and histomorphological study. J Bone Joint Surg Am 1988 1.15
17 Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 1987 1.05
18 Malignant germ cell tumors of the mediastinum. J Thorac Cardiovasc Surg 1985 1.04
19 Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys 1997 1.01
20 Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system. Int J Radiat Oncol Biol Phys 1990 0.99
21 Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial. J Clin Oncol 1994 0.98
22 Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma. Arch Ophthalmol 1997 0.98
23 Osteosarcoma of the spine. J Bone Joint Surg Am 1986 0.98
24 Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma. J Clin Oncol 1993 0.96
25 Results of radiotherapy for chemodectomas. Mayo Clin Proc 1992 0.95
26 Therapeutic radiation and hyperparathyroidism. A case-control study in Rochester, Minn. Arch Intern Med 1989 0.95
27 Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 1987 0.94
28 Stereotactic radiosurgery for glomus jugulare tumors: a preliminary report. Int J Radiat Oncol Biol Phys 1997 0.93
29 The role of stereotactic radiosurgery in the treatment of malignant skull base tumors. Int J Radiat Oncol Biol Phys 1997 0.93
30 External beam irradiation for retinoblastoma: patterns of failure and dose-response analysis. Int J Radiat Oncol Biol Phys 1989 0.93
31 Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52. Int J Radiat Oncol Biol Phys 1999 0.92
32 Treatment outcome and complications in patients treated for malignant epidural spinal cord compression (SCC). J Neurooncol 1985 0.89
33 Prognostic significance of mediastinal mass in adult Hodgkin's disease. Cancer 1984 0.88
34 Local control and complications after radiation therapy for primary orbital lymphoma: a case for low-dose treatment. Int J Radiat Oncol Biol Phys 1991 0.87
35 Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia. Cancer 1989 0.87
36 Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. Int J Radiat Oncol Biol Phys 1996 0.86
37 Intraoperative and external beam irradiation with or without resection: Mayo pilot experience. Mayo Clin Proc 1984 0.86
38 Primary anterior mediastinal seminoma. Cancer 1982 0.86
39 Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma. J Neurooncol 1997 0.86
40 Radiotherapeutic management of adult intraspinal ependymomas. Int J Radiat Oncol Biol Phys 1986 0.85
41 Computer-assisted stereotaxic biopsy for the diagnosis of primary central nervous system lymphoma. Neurology 1987 0.85
42 Primary lymphoma of the testis. Int J Radiat Oncol Biol Phys 1982 0.85
43 Nuclear deoxyribonucleic acid content measured by static cytometry: important prognostic association for patients with clinically localized prostate carcinoma treated by external beam radiotherapy. J Urol 1992 0.84
44 Radiotherapeutic management of primary thyroid lymphoma. Int J Radiat Oncol Biol Phys 1985 0.83
45 Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy. Am J Clin Oncol 2000 0.83
46 Postoperative radiotherapy of supratentorial low-grade gliomas. Int J Radiat Oncol Biol Phys 1989 0.83
47 Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology 1988 0.83
48 Primary retroperitoneal seminoma. Cancer 1982 0.83
49 Polymorphic reticulosis: a reappraisal. Hum Pathol 1994 0.82
50 Choroidal melanoma treatment with iodine 125 brachytherapy. Arch Ophthalmol 1987 0.82
51 Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladder. J Urol 1992 0.81
52 Patterns of failure in primary testicular non-Hodgkin's lymphoma. J Clin Oncol 1988 0.81
53 Long-term follow-up of radical retropubic prostatectomy for prostate cancer. Eur Urol 2002 0.81
54 A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1980 0.81
55 Testicular seminoma metastatic to the prostate. J Urol 1986 0.81
56 Initial chemotherapy doses for elderly patients with malignant lymphoma. J Clin Oncol 1986 0.80
57 Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma. Leuk Lymphoma 1994 0.79
58 Radiotherapy as initial treatment for bulky stage II testicular seminomas. J Clin Oncol 1985 0.79
59 Radiosensitivity in vitro of human fibroblasts derived from patients with a severe skin reaction to radiation therapy. Int J Radiat Oncol Biol Phys 1980 0.78
60 Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy. Int J Radiat Oncol Biol Phys 2000 0.78
61 Management of stage IE primary gastric lymphoma. Acta Haematol 1995 0.78
62 Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma. J Clin Oncol 1987 0.78
63 Modern radiotherapy results with bulky stages II and III seminoma. J Urol 1990 0.78
64 The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group. Neuro Oncol 1999 0.78
65 Supervoltage radiation therapy of the testicular tumors. Am J Roentgenol Radium Ther Nucl Med 1973 0.78
66 Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience. Mayo Clin Proc 1990 0.77
67 Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. Int J Radiat Oncol Biol Phys 1996 0.76
68 Second malignant lesions after therapy for Hodgkin's disease. Mayo Clin Proc 1984 0.76
69 Comparison of "orthovoltage" X-ray versus "megavoltage" electrons in treating tumors near the eye. Int J Radiat Oncol Biol Phys 1992 0.75
70 Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma. Invest New Drugs 1988 0.75
71 Failure of preenucleation radiation to decrease uveal melanoma mortality. The Collaborative Ocular melanoma Study Steering Committee. Am J Ophthalmol 1989 0.75
72 Hodgkin's disease with bulky mediastinal involvement. Int J Radiat Oncol Biol Phys 1993 0.75
73 A rapid optical method for preparation of complex field shapes. Radiology 1967 0.75
74 Postoperative irradiation for tonsillar carcinoma. Mayo Clin Proc 1993 0.75
75 A measurement of doses to the neck for mantle field treatment of lymphomas with cobalt-60, 4-, and 10-MV photon beams. Radiology 1982 0.75
76 Bone metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 0.75
77 A plea for prospective clinical trials. Int J Radiat Oncol Biol Phys 1987 0.75
78 Indium bone marrow scintigraphy as an aid in selecting marrow biopsy sites for the evaluation of marrow elements in patients with lymphoma. Cancer 1976 0.75
79 Alzheimer's disease and prior therapeutic radiation exposure: a case-control study. Neurology 1990 0.75
80 Primary testicular seminoma: prognostic significance of nuclear DNA ploidy pattern. Eur Urol 1997 0.75
81 Localization of the prostatic apex for radiotherapy treatment planning using urethroscopy. Int J Radiat Oncol Biol Phys 1997 0.75
82 Results from the Collaborative Ocular Melanoma Study (COMS) of enucleation versus preoperative radiation therapy in the management of large ocular melanomas. Int J Radiat Oncol Biol Phys 1999 0.75
83 Management of subdiaphragmatic early-stage Hodgkin's disease. Int J Radiat Oncol Biol Phys 1989 0.75
84 Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivity. Mayo Clin Proc 1987 0.75
85 Value of 111Indium chloride bone marrow scanning in the differential diagnosis of blood count depression in lymphoma. Cancer 1978 0.75
86 The accuracy of 111InCl3 as a bone marrow scanning agent. Radiology 1976 0.75
87 Definitive radiotherapy of primary mediastinal seminoma. Am J Roentgenol Radium Ther Nucl Med 1969 0.75
88 Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphoma. Cancer 1988 0.75
89 Nasal and nasopharyngeal angiocentric T-cell lymphomas. Laryngoscope 1996 0.75
90 Patterns of failure after total laryngectomy for glottic carcinoma. Cancer 1989 0.75
91 Lethal and hematologic effects of 14.6 MeV neutrons on beagles with estimation of RBE. Radiat Res 1971 0.75
92 Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancer. Med Pediatr Oncol 1981 0.75
93 The selection, acceptance testing, and quality control of radiotherapy treatment simulators. Radiology 1979 0.75
94 Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy. Mayo Clin Proc 1992 0.75